Press Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
physIQ and CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development
March 17, 2022
More infoPress Releases
CellCarta Expands its Biomarker Capabilities for Clinical Trials by adding Olink Technology to its Global Services
August 31, 2021
Proteomics/Mass Spectrometry
More infoPress Releases
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
January 26, 2021
More infoPress Releases
Caprion-HistoGeneX expands its histological biomarker franchise by joining forces with Mosaic Laboratories
January 12, 2021
Histopathology
More infoPress Releases
Caprion-HistoGeneX acquires
Clinical Logistics Inc. – A virtual central specimen management CRO
January 7, 2021
More infoPress Releases
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to advance infectious disease research
August 6, 2020
Immune Monitoring
More infoPress Releases
Caprion-HistoGeneX is offering molecular COVID-19 testing services while expanding its biomarker capabilities
June 22, 2020
Immune Monitoring
More infoPress Releases
Barts Cancer Institute and HistoGeneX Published Novel Research in Nature Medicine
November 12, 2019
Histopathology
More info